---
title: "Single-cell genomics in rheumatoid arthritis: from synovial niches to new therapies"
id: "nature-immunology-2-immune-mediated-rheumatoid-arthritis-from-single-cell-genomics-to-new-therapies"
canonical_url: "https://medichelpline.com/clinical-feed/nature-immunology-2-immune-mediated-rheumatoid-arthritis-from-single-cell-genomics-to-new-therapies"
content_type: "clinical_feed_article"
specialty: "Rheumatology"
source_name: "Nature Immunology"
source_url: "https://www.nature.com/articles/s41590-026-02639-8"
published_at: "2026-08-31T11:59:37.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Single-cell genomics in rheumatoid arthritis: from synovial niches to new therapies
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/nature-immunology-2-immune-mediated-rheumatoid-arthritis-from-single-cell-genomics-to-new-therapies
- **Specialty:** [Rheumatology](https://medichelpline.com/clinical-feed/rheumatology.md)
- **Primary Source:** Nature Immunology
- **Source URL:** [Original Journal Publication](https://www.nature.com/articles/s41590-026-02639-8)
- **Published At:** 2026-08-31T11:59:37.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The application of **single-cell genomics** to immune-mediated arthritis has produced an extensive, rapidly expanding dataset that reveals diverse immune and stromal cell subsets in diseased joints. - Studies report novel **lymphocyte**, **myeloid** and **fibroblast** populations in the rheumatoid synovium that are proposed to have pathogenic roles. - Most single-cell findings are descriptive and correlative; a central challenge is converting these maps into mechanistic, causal insights relevant to disease pathogenesis. - Emerging approaches to address causality include **spatial transcriptomics** to define tissue niches, ex vivo mechanistic experiments, organoid models and cassette use of human-data–informed animal models. - Spatial methods reveal organized **synovial niches** and localized interactions among immune, stromal and endothelial cells that may drive pathology. - Ex vivo and organoid studies enable mechanistic interrogation of cell–cell interactions and functional states identified by single-cell profiling, bridging descriptive data and experimental manipulation. - Animal models that are better aligned to human synovial features informed by human single-cell data can help test hypotheses about drivers of disease and potential interventions. - Insights derived from integrating single-cell, spatial and mechanistic studies can guide the rational design of new therapeutic strategies and shape clinical trial approaches in **rheumatoid arthritis**. - The concepts and methods discussed for RA have potential applicability across other tissues and immune-mediated diseases, offering a general framework to translate high-resolution cellular maps into therapies. - Figures in the source highlight immune infiltration and expansion of the RA **synovium**, spatial transcriptomic identification of synovial niches, and modeling of niches in animal systems; the source emphasizes that the field must move from descriptive atlases toward causal and translational studies.
## Clinical Analysis & Structured Key Points
## Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our [privacy policy](https://www.nature.com/info/privacy) for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Reject optional cookies [Skip to main content](https://www.nature.com/articles/s41590-026-02639-8#content) Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement [ ![Nature Immunology](https://media.springernature.com/full/nature-cms/uploads/product/ni/header-ce329d5b570f961b651db20c364a103a.svg) ](https://www.nature.com/ni) * [ View all journals ](https://www.nature.com/siteindex) * [ Saved research ](https://www.nature.com/saved-research) * [ Search ](javascript:;) ## Search Search articles by subject, keyword or author Show results from All journals This journal Search [ Advanced search ](https://www.nature.com/search/advanced) ### Quick links * [Explore articles by subject](https://www.nature.com/subjects) * [Find a job](https://www.nature.com/naturecareers) * [Guide to authors](https://www.nature.com/authors/index.html) * [Editorial policies](https://www.nature.com/authors/editorial_policies/) * [Log in](https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41590-026-02639-8) * [ Content Explore content ](javascript:;) ## Explore content * [ Research articles ](https://www.nature.com/ni/research-articles) * [ Reviews & Analysis ](https://www.nature.com/ni/reviews-and-analysis) * [ News & Comment ](https://www.nature.com/ni/news-and-comment) * [ Videos ](https://www.nature.com/ni/video) * [ Current issue ](https://www.nature.com/ni/current-issue) * [ Collections ](https://www.nature.com/ni/collections) * [Follow us on X ](https://twitter.com/NatImmunol) * [ Subscribe ](https://www.nature.com/ni/subscribe) * [Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) * [ About the journal ](javascript:;) ## About the journal * [ Aims & Scope ](https://www.nature.com/ni/aims) * [ Journal Information ](https://www.nature.com/ni/journal-information) * [ Journal Metrics ](https://www.nature.com/ni/journal-impact) * [ About the Editors ](https://www.nature.com/ni/editors) * [ Research Cross-Journal Editorial Team ](https://www.nature.com/ni/research-cross-journal-editorial-team) * [ Reviews Cross-Journal Editorial Team ](https://www.nature.com/ni/reviews-cross-journal-editorial-team) * [ Our publishing models ](https://www.nature.com/ni/our-publishing-models) * [ Editorial Values Statement ](https://www.nature.com/ni/editorial-values-statement) * [ Editorial Policies ](https://www.nature.com/ni/editorial-policies) * [ Content Types ](https://www.nature.com/ni/content) * [ Web Feeds ](https://www.nature.com/ni/web-feeds) * [ Posters ](https://www.nature.com/ni/posters) * [ Contact ](https://www.nature.com/ni/contact) * [ Publish with us ](javascript:;) ## Publish with us * [ Submission Guidelines ](https://www.nature.com/ni/submission-guidelines) * [ For Reviewers ](https://www.nature.com/ni/for-reviewers) * [ Language editing services ](https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022) * [Open access funding](https://www.nature.com/ni/open-access-funding) * [Submit manuscript ](https://mts-ni.nature.com/cgi-bin/main.plex) * [ Subscribe ](https://www.nature.com/ni/subscribe) * [ Sign up for alerts ](https://journal-alerts.springernature.com/subscribe?journal_id=41590) * [ RSS feed ](https://www.nature.com/ni.rss) 1. [nature](https://www.nature.com/) 2. [nature immunology](https://www.nature.com/ni) 3. [perspectives](https://www.nature.com/ni/articles?type=perspective) 4. article * Perspective * Published: 31 August 2026 # Immune-mediated rheumatoid arthritis: from single-cell genomics to new therapies * [Lionel B. Ivashkiv](https://www.nature.com/articles/s41590-026-02639-8#auth-Lionel_B_-Ivashkiv-Aff1-Aff2-Aff3) [ORCID: orcid.org/0000-0002-9951-0646](https://orcid.org/0000-0002-9951-0646)[1](https://www.nature.com/articles/s41590-026-02639-8#Aff1),[2](https://www.nature.com/articles/s41590-026-02639-8#Aff2),[3](https://www.nature.com/articles/s41590-026-02639-8#Aff3) [_Nature Immunology_](https://www.nature.com/ni) (2026) [Cite this article](https://www.nature.com/articles/s41590-026-02639-8#citeas) [ Save article ](https://www.nature.com/articles/s41590-026-02639-8/save-research?_csrf=oJbaQhIkYG9tWD88NI6kkNOfXkDox9V8) [ View saved research ](https://www.nature.com/saved-research) ## Abstract The recent application of single-cell genomics to the investigation of immune-mediated arthritis has resulted in an explosion of information, including the discovery of lymphocyte, myeloid and fibroblast cell subsets proposed to be pathogenic. A challenge in the field is how to leverage these exciting but largely descriptive and correlative datasets to gain insights into causality and mechanisms of disease. In this Perspective, I describe emerging data and discuss ideas about how spatial transcriptomics, ex vivo mechanistic and organoid studies, and improved use of animal models based on human disease data can advance the understanding of immune-mediated arthritis pathogenesis, with a focus on rheumatoid arthritis. These insights can form the basis for designing new therapeutic strategies and implementing clinical trials. The concepts and approaches described here for arthritis may have broader applicability to other tissues and immune-mediated diseases. This is a preview of subscription content, [access via your institution](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41590-026-02639-8) ## Access options [ Access through your institution ](https://wayf.springernature.com?redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41590-026-02639-8) Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 € / 30 days cancel any time [Learn more](https://shop.nature.com/products/plus/?region=ROW) Subscribe to this journal Receive 12 print issues and online access 251,40 € per year only 20,95 € per issue [Learn more](https://www.nature.com/ni/subscribe) Buy this article * Purchase on SpringerLink * Instant access to the full article PDF. 39,95 € Prices may be subject to local taxes which are calculated during checkout ### Additional access options: * [Log in](https://idp.nature.com/authorize/natureuser?client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41590-026-02639-8) * [Learn about institutional subscriptions](https://www.springernature.com/gp/librarians/licensing/license-options) * [Read our FAQs](https://support.nature.com/en/support/home) * [Contact customer support](https://www.springernature.com/gp/contact) **Fig. 1: Immune infiltration and expansion of the RA synovium.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41590-026-02639-8/MediaObjects/41590_2026_2639_Fig1_HTML.png) **Fig. 2: Spatial transcriptomics reveals synovial niches.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41590-026-02639-8/MediaObjects/41590_2026_2639_Fig2_HTML.png) **Fig. 3: Spatial transcriptomics reveals synovial niches in ZIA that model aspects of RA.** ![](https://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41590-026-02639-8/MediaObjects/41590_2026_2639_Fig3_HTML.png) ### Explore related subjects Discover the latest articles and news in related subjects. * [Autoimmunity](https://www.nature.com/subjects/autoimmunity) * [Innate immunity](https://www.nature.com/subjects/innate-immunity) * [Translational immunology](https://www.nature.com/subjects/translational-immunology) ## References 1. Alivernini, S., Firestein, G. S. & McInnes, I. B. The pathogenesis of rheumatoid arthritis. _Immunity_ **55** , 2255–2270 (2022). [Article](https://doi.org/10.1016%2Fj.immuni.2022.11.009) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XjtFSjtbvM) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36516818) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=The%20pathogenesis%20of%20rheumatoid%20arthritis&journal=Immunity&doi=10.1016%2Fj.immuni.2022.11.009&volume=55&pages=2255-2270&publication_year=2022&author=Alivernini%2CS&author=Firestein%2CGS&author=McInnes%2CIB) 2. Gravallese, E. M. & Firestein, G. S. Rheumatoid arthritis - common origins, divergent mechanisms. _N. Engl. J. Med._ **388** , 529–542 (2023). [Article](https://doi.org/10.1056%2FNEJMra2103726) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3sXjtlentL8%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=36780677) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Rheumatoid%20arthritis%20-%20common%20origins%2C%20divergent%20mechanisms&journal=N.%20Engl.%20J.%20Med.&doi=10.1056%2FNEJMra2103726&volume=388&pages=529-542&publication_year=2023&author=Gravallese%2CEM&author=Firestein%2CGS) 3. Weyand, C. M. & Goronzy, J. J. The immunology of rheumatoid arthritis. _Nat. Immunol._ **22** , 10–18 (2021). [Article](https://doi.org/10.1038%2Fs41590-020-00816-x) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisVClur3O) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=33257900) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=The%20immunology%20of%20rheumatoid%20arthritis&journal=Nat.%20Immunol.&doi=10.1038%2Fs41590-020-00816-x&volume=22&pages=10-18&publication_year=2021&author=Weyand%2CCM&author=Goronzy%2CJJ) 4. Perera, J., Delrosso, C. A., Nerviani, A. & Pitzalis, C. Clinical phenotypes, serological biomarkers, and synovial features defining seropositive and seronegative rheumatoid arthritis: a literature review. _Cells_ **13** , 743 (2024). [Article](https://doi.org/10.3390%2Fcells13090743) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtFOlsLfF) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=38727279) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11083059) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Clinical%20phenotypes%2C%20serological%20biomarkers%2C%20and%20synovial%20features%20defining%20seropositive%20and%20seronegative%20rheumatoid%20arthritis%3A%20a%20literature%20review&journal=Cells&doi=10.3390%2Fcells13090743&volume=13&publication_year=2024&author=Perera%2CJ&author=Delrosso%2CCA&author=Nerviani%2CA&author=Pitzalis%2CC) 5. Pitzalis, C., Choy, E. H. S. & Buch, M. H. Transforming clinical trials in rheumatology: towards patient-centric precision medicine. _Nat. Rev. Rheumatol._ **16** , 590–599 (2020). [Article](https://doi.org/10.1038%2Fs41584-020-0491-4) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32887976) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Transforming%20clinical%20trials%20in%20rheumatology%3A%20towards%20patient-centric%20precision%20medicine&journal=Nat.%20Rev.%20Rheumatol.&doi=10.1038%2Fs41584-020-0491-4&volume=16&pages=590-599&publication_year=2020&author=Pitzalis%2CC&author=Choy%2CEHS&author=Buch%2CMH) 6. Cope, A. P., Schulze-Koops, H. & Aringer, M. The central role of T cells in rheumatoid arthritis. _Clin. Exp. Rheumatol._ **25** , S4–S11 (2007). [CAS](https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BD2snosV2rtA%3D%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17977483) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=The%20central%20role%20of%20T%20cells%20in%20rheumatoid%20arthritis&journal=Clin.%20Exp.%20Rheumatol.&volume=25&pages=S4-S11&publication_year=2007&author=Cope%2CAP&author=Schulze-Koops%2CH&author=Aringer%2CM) 7. Deane, K. D. et al. Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease. _Ann. Rheum. Dis._ **84** , 14–28 (2025). [Article](https://doi.org/10.1136%2Fard-2023-224211) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2MXkslGju78%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=39874228) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Therapeutic%20interception%20in%20individuals%20at%20risk%20of%20rheumatoid%20arthritis%20to%20prevent%20clinically%20impactful%20disease&journal=Ann.%20Rheum.%20Dis.&doi=10.1136%2Fard-2023-224211&volume=84&pages=14-28&publication_year=2025&author=Deane%2CKD) 8. Cappelli, L. C. Immune checkpoint inhibitors and rheumatoid arthritis: all roads lead to PD-1?. _Semin. Arthritis Rheum._ **70S** , 152582 (2025). [Article](https://doi.org/10.1016%2Fj.semarthrit.2024.152582) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=39578183) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Immune%20checkpoint%20inhibitors%20and%20rheumatoid%20arthritis%3A%20all%20roads%20lead%20to%20PD-1%3F&journal=Semin.%20Arthritis%20Rheum.&doi=10.1016%2Fj.semarthrit.2024.152582&volume=70S&publication_year=2025&author=Cappelli%2CLC) 9. Rao, D. A. et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. _Nature_ **542** , 110–114 (2017). [Article](https://doi.org/10.1038%2Fnature20810) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXitVWns74%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28150777) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349321) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Pathologically%20expanded%20peripheral%20T%20helper%20cell%20subset%20drives%20B%20cells%20in%20rheumatoid%20arthritis&journal=Nature&doi=10.1038%2Fnature20810&volume=542&pages=110-114&publication_year=2017&author=Rao%2CDA) 10. Argyriou, A. et al. Innate immune cell subsets are enriched in synovial fluid of ACPA-negative rheumatoid arthritis and characterized by distinct type I IFN gene signatures. _Ann. Rheum. Dis._ **85** , 265–275 (2026). [Article](https://doi.org/10.1016%2Fj.ard.2025.07.029) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB28XmvFamu78%3D) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=41046204) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Innate%20immune%20cell%20subsets%20are%20enriched%20in%20synovial%20fluid%20of%20ACPA-negative%20rheumatoid%20arthritis%20and%20characterized%20by%20distinct%20type%20I%20IFN%20gene%20signatures&journal=Ann.%20Rheum.%20Dis.&doi=10.1016%2Fj.ard.2025.07.029&volume=85&pages=265-275&publication_year=2026&author=Argyriou%2CA) 11. Argyriou, A. et al. Single cell sequencing identifies clonally expanded synovial CD4+ TPH cells expressing GPR56 in rheumatoid arthritis. _Nat. Commun._ **13** , 4046 (2022). [Article](https://doi.org/10.1038%2Fs41467-022-31519-6) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhvVChtLbP) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35831277) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279430) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Single%20cell%20sequencing%20identifies%20clonally%20expanded%20synovial%20CD4%2B%20TPH%20cells%20expressing%20GPR56%20in%20rheumatoid%20arthritis&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-022-31519-6&volume=13&publication_year=2022&author=Argyriou%2CA) 12. Bolton, C. et al. Synovial tissue atlas in juvenile idiopathic arthritis reveals pathogenic niches associated with disease severity. _Sci. Transl. Med._ **17** , eadt6050 (2025). [Article](https://doi.org/10.1126%2Fscitranslmed.adt6050) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2MXhsF2ltbjE) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=40601776) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7617933) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Synovial%20tissue%20atlas%20in%20juvenile%20idiopathic%20arthritis%20reveals%20pathogenic%20niches%20associated%20with%20disease%20severity&journal=Sci.%20Transl.%20Med.&doi=10.1126%2Fscitranslmed.adt6050&volume=17&publication_year=2025&author=Bolton%2CC) 13. Dunlap, G. et al. Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium. _Nat. Commun._ **15** , 4991 (2024). [Article](https://doi.org/10.1038%2Fs41467-024-49186-0) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtl2msL7N) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=38862501) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167034) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Clonal%20associations%20between%20lymphocyte%20subsets%20and%20functional%20states%20in%20rheumatoid%20arthritis%20synovium&journal=Nat.%20Commun.&doi=10.1038%2Fs41467-024-49186-0&volume=15&publication_year=2024&author=Dunlap%2CG) 14. He, C. et al. A single-cell RNA-seq dataset of synovial fluid from rheumatoid arthritis treated with TNF-α/JAK inhibitor. _Sci. Data_ **12** , 977 (2025). [Article](https://doi.org/10.1038%2Fs41597-025-05339-4) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB2MXhsFKgsb3M) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=40494845) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152119) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=A%20single-cell%20RNA-seq%20dataset%20of%20synovial%20fluid%20from%20rheumatoid%20arthritis%20treated%20with%20TNF-%CE%B1%2FJAK%20inhibitor&journal=Sci.%20Data&doi=10.1038%2Fs41597-025-05339-4&volume=12&publication_year=2025&author=He%2CC) 15. Jonsson, A. H. et al. Granzyme K+ CD8 T cells form a core population in inflamed human tissue. _Sci. Transl. Med._ **14** , eabo0686 (2022). [Article](https://doi.org/10.1126%2Fscitranslmed.abo0686) [CAS](https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhsF2jurnP) [PubMed](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=35704599) [PubMed Central](http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972878) [ Google Scholar](http://scholar.google.com/scholar_lookup?&title=Granzyme%20K%2B%20CD8%20T%20cells%20form%20a%20core%20population%20in%20inflamed%20human%20tissue&journal=Sci.%20Transl.%20Med.&doi=10
## Related Clinical Research

- [Effectiveness and Safety of Tocilizumab in Refractory Rheumatoid Arthritis: A Moroccan Study](https://medichelpline.com/clinical-feed/medrxiv-12-real-world-effectiveness-and-safety-of-tocilizumab-in-refractory-rheumatoid.md)
- [CD19 CAR T-cell therapy (mivocabtagene autoleucel) in refractory seropositive rheumatoid arthritis](https://medichelpline.com/clinical-feed/nature-1-cd19-car-t-cell-therapy-for-treatment-refractory-seropositive-rheumatoid.md)
- [Post-translational neoantigens in rheumatoid arthritis: molecular mechanisms and therapeutic impli](https://medichelpline.com/clinical-feed/frontiers-in-immunology-9-molecular-basis-of-post-translational-neoantigen-generation-in-rheumatoid.md)
- [MicroRNAs in Immune-Related Diseases: Mechanisms, Functions and Therapeutic Perspectives](https://medichelpline.com/clinical-feed/frontiers-in-immunology-14-micrornas-in-immune-related-diseases-mechanism-functions-and-therapeutic.md)
- [Brief-COPE Questionnaire Shows Five-Factor Structure in Seropositive Rheumatoid Arthritis](https://medichelpline.com/clinical-feed/medrxiv-1-validation-of-the-brief-cope-questionnaire-in-a-seropositive-rheumatoid.md)

## Navigation
- [← Back to Rheumatology Feed](https://medichelpline.com/clinical-feed/rheumatology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.